🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don’t miss out on #TCT24! Proud to be on the PDC, sharing first-🫱 insights: -🚀 Innovation, ✂️ Science, 👀 Education! - 🔑Opinion Leaders + ⭐️Faculty! - 🔨Live Cases! - amazing Cardiovascular Research Foundation community 🌉gap btw #IC, #HeartFailure+#EP! See you in DC! Juan F. Granada Philipp Lurz

Very proud of this #EACTS 2024 ❤️ -presentation of interventional paper -resident committee starting position Most important, meet my old and new friends and colleagues from every part of the world ‼️❤️ Very blessed for all these amazing opportunities ⭐️ EACTS

Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation jamanetwork.com/journals/jama/… Philipp Lurz Julia Grapsa MD, PhD Cosyns Bernard @CHU

Luftnot nach #Lungenembolie. Die Ballon-Angioplastie (BPA) eröffnet neue Möglichkeiten zur Behandlung von inoperabler #CTEPH. Philipp Lurz tommaso gori Stavros Konstantinides Universitätsmedizin Mainz unimedizin-mainz.de/presse/pressem…

🚀 Personalized Management of TR? Take a quick dive into #TR mechanisms, including: ➡️ Forward & Backward Failure 🔄 Ventricular Interaction 💡 Impacts on TTVR 📰 Check out our latest CardioPulse piece in #EHJ: academic.oup.com/eurheartj/arti… Philipp Lurz Edoardo Zancanaro MD #ESC_Journals

Unsere Klinik, Zentrum für Kardiologie Universitätsmedizin Mainz konnte das 4. Jahr in Folge als FoBi Standort Junge Kardiologie 🫀 der Deutsche Gesellschaft für Kardiologie und Young DGK zertifiziert werden! Wir freuen uns sehr über diese tolle Auszeichnung 🏆 und spannende Fort-und Weiterbildung 2025 Philipp Lurz

our review article on RDN and role in heart failure by Franziska Koppe-Schmeißer Karl-Philipp Rommel Karl-Patrik Kresoja Marat Fudim, MD MHS

For patients with tricuspid regurgitation, the extent of disease appears to influence 1-year mortality following T-TEER, confirm new prospective European registry data. Philipp Lurz @arnoldgehrke tctmd.com/news/intermedi…

In this multicenter European registry, those patients in mid stage but not those in early or late stage of Tricuspid Regurgitation disease, showed significant 1-year survival with #TTEER vs conservative management. 4-parameter easy score to identify them. Thanks to the authors.

T-TEER improves 1-year survival in patients with intermediate-stage tricuspid regurgitation💡 No benefit seen in early or advanced stages 🚑 Timing of intervention is crucial for optimal outcomes! 🫀 jacc.org/doi/10.1016/j.… #TEER #Cardiology #vhdTR Philipp Lurz

Tricuspid Regurgitation Disease Stages and Treatment Outcomes After Transcatheter Tricuspid Valve Repair T-TEER was associated with 1-year survival at intermediate stage disease but not at early or advanced disease stages jacc.org/doi/10.1016/j.…

World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group Univ.-Prof. Dr. Ralph Stephan von Bardeleben AGIK Deutsche Gesellschaft für Kardiologie Edoardo Zancanaro MD Erik Rafflenbeul European Society of Cardiology Journals Holger Thiele

🔴 Your #PCRwebinar on the updates in #tricuspid interventions: from the procedure to follow-up is broadcasting now📡! Georg Nickenig, Dreyfus Julien, Saibal Kar and Philipp Lurz are waiting for you! 💻 [pcronline.com/Webinars/PCR-W…] (access via your free My PCR account) #MedEd

🎉Milestone Moment in Mainz, Germany!💯 We’re thrilled to celebrate 100 Trilogy valves implanted at Universitätsmedizin Mainz ! This achievement marks meaningful progress in offering transcatheter options for patients with severe aortic regurgitation. Thank you to the team Mainz for

Mayra Guerrero - Cardiovascular News cardiovascularnews.com/mayra-guerrero/ Hard work always pays off. Today was a very special moment as I arrived at the EuroPCR 2025 in Paris and saw that they were handing out this magazine featuring an interview with me, to highlight my professional career

📸 Day 2 of #EuroPCR in pictures From complications to comorbidities, EuroPCR shines a spotlight on the real clinical challenges you face 🔦 Browse the photos and see how Day 2 united your community in tackling complex situations together 💪 DrThomasCuisset nicolas dumonteil

Thoughtful presentations of device-based therapies to address gaps in heart failure on final day of #EuroPCR. So fun to comoderate with Philipp Lurz and hear more about UNLOAD HFpEF trial (renal denervation for HF) Recor Medical

Proud to join the newly launched #PCR Mitral Focus Group. 💎Led by Thomas Modine, Philip Lurz & Francesco Maisano, the group aims to: • Drive innovation • Advance phenotype-based standards • Align practice & knowledge • Address unmet clinical needs • Foster collaboration

What a fruitful #EuroPCR! Great interactions, hands on and world class practical teaching! State of the art simulations on structural heart and coronary interventions! Innovation, collaboration and beyond is what describes this conference! Proud to have been a small part of

Our sincere congratulations to Edoardo Zancanaro MD who received the Michele Pighi Young Investigator Award 🏆 during #EuroPCR 2025 for his work on "Long-term (>10 years) of transcatheter of mitral valve-in-valve implantation. francesco maisano